ClinicalTrials.Veeva

Menu

Management of Patients With Alpha-1 Antitrypsin Deficiency Associated Emphysema

A

Assistance Publique - Hôpitaux de Paris

Status

Unknown

Conditions

Emphysema
Alpha 1-Antitrypsin Deficiency

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The aim of this study is to describe the natural history of patients with alpha-1 antitrypsin associated emphysema and to figure out associated prognostic factors.

Full description

All patients who suffer from this disease are followed every 6 months during a 5 years period. FEV1 decline is the primary endpoint. Quality of life assessed using the Saint George's Respiratory Questionary is recorded too.

Enrollment

300 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Serum alpha one antitrypsin < 0.8 g/l
  • Emphysema diagnosed by CT scan
  • Adult
  • Obstructive disorder

Exclusion criteria

  • Liver or lung transplantation

Trial contacts and locations

1

Loading...

Central trial contact

Gabriel Thabut, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems